N4 Pharma (LON:N4P) Trading Up 16.4% – Should You Buy?

Shares of N4 Pharma Plc (LON:N4P) were up 16.4% on Wednesday . The stock traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.61 ($0.01). Approximately 9,648,380 shares traded hands during trading, an increase of 325% from the average daily volume of 2,270,169 shares. The stock had previously closed at GBX 0.53 ($0.01).

N4 Pharma Trading Up 0.8 %

The business’s 50-day simple moving average is GBX 0.62 and its two-hundred day simple moving average is GBX 0.57. The firm has a market capitalization of £2.39 million, a price-to-earnings ratio of -55.00 and a beta of -0.37. The company has a quick ratio of 7.28, a current ratio of 22.73 and a debt-to-equity ratio of 1.62.

N4 Pharma Company Profile

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.